Related Experiment Video
Updated: May 19, 2026

08:19
Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing
Published on: June 1, 2012
Dual-Interface Nanopore Array Sensor Revealing the Synergistic Oscillations of Lactate Efflux in Cancer Cells
Jia-Wei Gong1, Zi-Qiang Du1, Jian-Hua Guo2
1College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, China.
Angewandte Chemie (International Ed. in English)
|May 18, 2026
Summary
Researchers developed a novel sensor to measure lactate efflux from cancer cells, overcoming interference from reactive oxygen species (ROS). This technology revealed new insights into cancer metabolism and potential therapeutic targets.
Area of Science:
- Biomedical Engineering
- Cancer Metabolism
- Nanotechnology
Background:
- Lactate is crucial in tumor metabolism and signaling, influencing the tumor microenvironment.
- Understanding lactate efflux is key to cancer cell adaptation and stress response.
- Reactive oxygen species (ROS) interfere with traditional lactate sensing methods.
Purpose of the Study:
- To develop a sensor capable of accurately quantifying lactate efflux from cancer cells.
- To overcome the interference of endogenous reactive oxygen species (ROS) in lactate measurements.
- To investigate the dynamics of lactate efflux in response to stimuli.
Main Methods:
- Development of a dual-interface nanopore array sensor (DINAS).
- Integration of an anti-ROS interface and a lactate sensing interface.
- Culturing cancer cells on the sensor to monitor ROS and lactate diffusion.
Main Results:
- The DINAS sensor successfully quantified lactate efflux by removing ROS interference.
- Drug-induced lactate efflux showed a time-dependent "rise-then-fall" pattern, indicating metabolic reprogramming.
- A synergistic oscillation in lactate efflux at the cell population level was unexpectedly observed.
Conclusions:
- The DINAS sensor provides a robust method for studying cancer cell metabolism.
- Observed lactate efflux dynamics offer insights into cancer cell energy adaptation.
- The discovery of population-level lactate oscillation may lead to novel precision anticancer therapies targeting metabolic regulation.

